National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation
Clinical trials sponsored by National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Massive blood pressure registry aims to personalize care Results expected Dec 2026 (estimated)
- Blood thinner safety under the microscope: 2,000 heart patients enrolled Results expected Dec 2026 (estimated)
- Massive registry aims to uncover hidden risks of blood thinners in heart patients Results expected Dec 2026 (estimated)
- New pill aims to keep heart in rhythm after AFib episode Results expected Dec 2026 (estimated)
- Heart failure clues: study tracks 500 patients for 3 years Results expected Dec 2026 (estimated)
-
Could a diabetes drug ease heart failure in rare amyloid disease?
Symptom relief CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking distance, and heart stress markers ov…
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Digital nudges in medical records may boost heart failure care
Knowledge-focused CompletedThis completed study looked at whether clinical decision support systems (CDSS) built into electronic health records help doctors better follow guidelines for chronic heart failure. Researchers analyzed data from over 66,000 patients in Russia, checking if the system increased us…
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC